First Trust Advisors LP Novavax Inc Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $3.52 Million - $7.62 Million	610,427 New	610,427 $4.23 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $519,166 - $1.08 Million	-14,310 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $9.5 Million - $19.5 Million	-136,220 Reduced 90.49%	14,310 $1.05 Million
Q4 2021 Feb 08, 2022	SELL	$134.56 - $217.97 $18.9 Million - $30.7 Million	-140,621 Reduced 48.3%	150,530 $21.5 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $36.1 Million - $55 Million	203,135 Added 230.79%	291,151 $60.4 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $6.94 Million - $14.8 Million	57,354 Added 187.05%	88,016 $18.7 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $609,640 - $1.73 Million	-5,396 Reduced 14.96%	30,662 $5.56 Million
Q4 2020 Feb 02, 2021	BUY	$78.74 - $139.5 $2.84 Million - $5.03 Million	36,058 New	36,058 $4.02 Million

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.01B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.